Search is Powered by Google
Cancer / Oncology News

Taming, Then Aiming, Viruses At Brain Tumors - "Engineered" Viruses May Hold Promise For Cancer Treatment

Main Category: Cancer / Oncology
Article Date: 28 Jun 2008 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

3.75 (4 votes)

Health Professional:not yet rated

Article Opinions: 1 posts

It may sound like the plot of a medical drama, but this approach to fighting cancer is real. Scientists say they may someday be able to battle brain cancer, while using a virus to do it. Early results from the lab are promising.

The science itself may be complex, but the idea is relatively simple; modify a common virus that will bypass healthy cells and attack tumors. In some lab tests involving animals with brain cancer it's worked*.

"Even at that late stage of their tumor burden has lead to significant enhancement and survivaland sometimes even cures of some animals," says Balveen Kaur, MD at Ohio State University's Comprehensive Cancer Center.

Doctor Kaur says there is still work to do. One problem is that the immune system of some animals attack the virus and kills it before it can kill the cancer. So she is working on ways to slow the immune system so the virus can better pass through healthy cells and collect inside cancer cells. Once it does, the virus can multiply and destroy it.

"So if one virus particle goes inside the cell, it can replicate to become about 500 to 1,000 particles and then the infected cell literally bursts," says Kaur.

It's an idea that appeals to Brad Curran, who doesn't take walks with his dog for granted. It was his dog that saved his life. After finding him unconscious the dog went for help. It turns out Brad had a brain tumor and spent weeks in the hospital undergoing surgery, chemotherapy, and even learning to walk again. So the idea of a virus that could help battle tumors like his in the future is promising.

"I'm sure the recovery would be quicker and people could return to their normal activities and life and work and continue where they were," says Curran.

Human trials may still be a ways off, but researchers say they're taking important steps towards turning that idea into reality. Scientists say they have tested the virus on healthy brain tissue in humans and it has proven to be safe. One recent study at Ohio State found that combining the virus with drugs that stop blood vessels from reaching the tumor might be one way to attack and starve cancers in the brain.**

* Systemic Vesicular Stomatitis Virus Selectively Destroys Multifocal Glioma and Metastatic Carcinoma in Brain
The Journal of Neuroscience, Volume 28, Number 6,
February 2008. www.jneurosci.org

**Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
Molecular Therapy, The American Society of Gene Therapy, www.moleculartherapy.org

Ohio State and Nationwide Children's Hospital
http://www.nationwidechildrens.org
http://medicalcenter.osu.edu




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...